Knight Therapeutics | GUD - EPS Earnings Per Share


Knight Therapeutics reported CAD0.13 in EPS Earnings Per Share for its fiscal quarter ending in March of 2026.


Fiscal Calendar Actual Consensus Previous Date
FY2027Q1 Mar/2026 0.13 -0.01 0.04 May/07




Eps Change Date
Acasti Pharma USD -0.06 0.15 Sep/2025
Akebia Therapeutics USD -0.04 0.04 Dec/2025
Alaunos Therapeutics USD -0.52 0.02 Mar/2026
Aurora Cannabis CAD -0.64 0.36 Dec/2025
Avita Medical AUD -0.38 0 Dec/2025
Canopy Growth CAD -0.4 0.35 Mar/2026
Cronos Group USD 0.04 0.02 Mar/2026
Dianthus Therapeutics USD -1.43 0.46 Dec/2025
Ionis Pharmaceuticals USD -0.56 0.85 Mar/2026
IQVIA Holdings USD 2.9 0.52 Mar/2026
Knight Therapeutics CAD 0.13 0.22 Mar/2026
Moderna USD -3.4 1.29 Mar/2026
Omeros USD -1.12 0.37 Jun/2024
Organigram Holdings CAD -0.16 0.02 Dec/2025
Organon & Co USD 0.71 0.08 Mar/2026
Revvity USD 1.06 0.64 Mar/2026
Tectonic Therapeutic USD -1.03 0.01 Dec/2025
Tilray USD -0.41 0.4 Dec/2025
Viatris USD 0.59 0.02 Mar/2026
Xeris Pharmaceuticals USD 0.01 0.04 Mar/2026